Evolution of low HER2 expression between early and advanced-stage breast cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Paolo,Tarantino ^[1] ; Sara,Gandini ^[1] ; Eleonora,Nicolò ^[1] ; Pamela,Trillo ^[1] ; Federica,Giugliano ^[1] ; Paola,Zagami ^[1] ; Grazia,Vivanet ^[1] ; Federica,Bellerba ^[2] ; Dario,Trapani ^[1] ; Antonio,Marra ^[1] ; Angela,Esposito ^[3] ; Carmen,Criscitiello ^[1] ; Giuseppe,Viale ^[1] ; Giuseppe,Curigliano ^[4]

作者单位： European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. ^[1] University of Milan, Milan, Italy. ^[2] European Institute of Oncology IRCCS, Milan, Italy. ^[3] European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. Electronic address: Giuseppe.curigliano@ieo.it. ^[4]

关键词 Antibody-drug conjugates Breast cancer HER2 dynamics HER2 expression HER2-Low

主题词乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);预后(Prognosis)

DOI 10.1016/j.ejca.2021.12.022

PMID 35032815

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交